COMMUNIQUÉS West-GlobeNewswire

-
Saudi Arabia’s KFSHRC Continues to Rise as a Globally Renowned Medical Centre
09/02/2025 - 12:08 -
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated
08/02/2025 - 00:35 -
MEDIA ADVISORY: Public healthcare advocates to protest at Minister of Health Sylvia Jones’ office
08/02/2025 - 02:09 -
REPEAT - MEDIA ADVISORY: Public healthcare advocates to protest at Minister of Health Sylvia Jones’ office
08/02/2025 - 14:00 -
4DMT Presents Positive 52-Week Results from Phase 2b Cohort of PRISM Wet AMD Study and Long-term Durability Data Supporting 4D-150 4FRONT Global Registration Program
08/02/2025 - 20:30 -
Three-Year Results for EYLEA HD® (aflibercept) Injection 8 mg in Patients with Wet Age-related Macular Degeneration Demonstrate Continued Durable Vision Gains and Anatomic Improvements with Extended Dosing Intervals
08/02/2025 - 21:55 -
Firefly Neuroscience Congratulates Scientific Advisor, Dr. Christopher Wilson, Recipient of Prestigious UW Faculty of Engineering Award for Work on Superconducting Quantum Electronics
07/02/2025 - 13:30 -
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07/02/2025 - 13:30 -
Matinas BioPharma Appoints Evelyn D’An to Board of Directors as Audit Committee Chair
07/02/2025 - 13:30 -
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
07/02/2025 - 13:54 -
Neuronetics Announces Pricing of $18 Million Underwritten Public Offering of Common Stock
07/02/2025 - 13:54 -
Conduit Pharmaceuticals Transitions to Phase II of Sarborg Collaboration to Support AI-Driven Drug Development
07/02/2025 - 14:00 -
PROCEPT BioRobotics® to Report Fourth Quarter 2024 Financial Results on February 25, 2025 and Attend the TD Cowen 45th Annual Healthcare Conference and the 2025 Leerink Partners Healthcare Conference
07/02/2025 - 14:00 -
ITM to Present at Oppenheimer’s 35th Annual Healthcare Life Sciences Conference
07/02/2025 - 14:00 -
Annovis to Present at Oppenheimer's 35th Annual Healthcare Life Sciences Conference
07/02/2025 - 14:00 -
Medera, Inc. to Participate in Two Upcoming Investor Conferences
07/02/2025 - 14:00 -
Processa Pharmaceuticals to Present at the 2025 BIO CEO & Investor Conference
07/02/2025 - 14:00 -
Maze Therapeutics Doses First Patient in Phase 2 HORIZON Clinical Trial Evaluating MZE829 as a Potential Treatment for APOL1 Kidney Disease
07/02/2025 - 14:00 -
Nusano to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference
07/02/2025 - 14:00
Pages